Nirmeen A. Sabry

1.4k total citations
70 papers, 973 citations indexed

About

Nirmeen A. Sabry is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Nirmeen A. Sabry has authored 70 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Surgery. Recurrent topics in Nirmeen A. Sabry's work include Pharmaceutical Practices and Patient Outcomes (9 papers), Hepatitis C virus research (5 papers) and Patient Safety and Medication Errors (5 papers). Nirmeen A. Sabry is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (9 papers), Hepatitis C virus research (5 papers) and Patient Safety and Medication Errors (5 papers). Nirmeen A. Sabry collaborates with scholars based in Egypt, United Kingdom and United States. Nirmeen A. Sabry's co-authors include Samar Farid, Emad Omar, Dalia Dawoud, Maggie Abbassi, Nevine Shawky Abdelmalak, Alia Badawi, Ahmed Kamel, Rehab Nabil Shamma, Manal H. El‐Sayed and Doaa H. Abdelaziz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Critical Care Medicine and Journal of Ethnopharmacology.

In The Last Decade

Nirmeen A. Sabry

60 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nirmeen A. Sabry Egypt 16 205 146 140 108 99 70 973
Eman Abu‐Gharbieh United Arab Emirates 20 127 0.6× 154 1.1× 62 0.4× 73 0.7× 292 2.9× 90 1.2k
Nusrat Shafiq India 19 116 0.6× 51 0.3× 110 0.8× 243 2.3× 125 1.3× 86 1.0k
Torsten Hoppe‐Tichy Germany 23 318 1.6× 177 1.2× 52 0.4× 101 0.9× 121 1.2× 77 1.5k
Katsuhiko Matsuura Japan 18 132 0.6× 76 0.5× 184 1.3× 27 0.3× 78 0.8× 68 1.1k
Nicole Hunfeld Netherlands 21 293 1.4× 130 0.9× 27 0.2× 124 1.1× 79 0.8× 84 1.2k
Robert Janknegt Netherlands 13 223 1.1× 52 0.4× 46 0.3× 95 0.9× 90 0.9× 48 817
Henry J. Mann United States 20 184 0.9× 64 0.4× 33 0.2× 39 0.4× 110 1.1× 58 1.3k
Lynda S. Welage United States 23 185 0.9× 78 0.5× 243 1.7× 34 0.3× 179 1.8× 72 1.8k
Mark A. Gill United States 17 199 1.0× 43 0.3× 49 0.3× 63 0.6× 85 0.9× 60 987
Surulivelrajan Mallayasamy India 14 68 0.3× 97 0.7× 104 0.7× 23 0.2× 100 1.0× 62 794

Countries citing papers authored by Nirmeen A. Sabry

Since Specialization
Citations

This map shows the geographic impact of Nirmeen A. Sabry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirmeen A. Sabry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirmeen A. Sabry more than expected).

Fields of papers citing papers by Nirmeen A. Sabry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirmeen A. Sabry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirmeen A. Sabry. The network helps show where Nirmeen A. Sabry may publish in the future.

Co-authorship network of co-authors of Nirmeen A. Sabry

This figure shows the co-authorship network connecting the top 25 collaborators of Nirmeen A. Sabry. A scholar is included among the top collaborators of Nirmeen A. Sabry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirmeen A. Sabry. Nirmeen A. Sabry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabry, Nirmeen A., et al.. (2025). Impact of pharmacist led mobile application on medication adherence and efficacy in chronic kidney disease. npj Digital Medicine. 8(1). 325–325.
2.
Farid, Samar, et al.. (2025). Adjuvant nefopam versus standard of care in mechanically ventilated surgical critically ill patients: A randomized, double-blind controlled study. Anaesthesia Critical Care & Pain Medicine. 44(3). 101518–101518.
3.
Salem, Salem, et al.. (2025). The nephroprotective effect of metformin with cisplatin in bladder cancer: randomized clinical trial. International Urology and Nephrology. 57(11). 3611–3624.
4.
Sabry, Nirmeen A., et al.. (2024). Common bacterial and fungal infections as a challenging condition In cancer patients : Single centre based study. SHILAP Revista de lepidopterología. 0(0). 0–0.
5.
Abbassi, Maggie, et al.. (2024). Knowledge, Attitude, and Practice Towards Antibiotics Use Among Medical Sector Final-Year Students in Egypt. Medical Science Educator. 34(6). 1369–1379. 1 indexed citations
6.
7.
Sabry, Nirmeen A., et al.. (2023). Virtual clinical pharmacy training in the era of COVID-19: A report on undergraduate students' perceptions and academic performance. Currents in Pharmacy Teaching and Learning. 15(1). 8–18. 1 indexed citations
8.
Abbassi, Maggie, et al.. (2023). The effect of vitamin K4 supplementation on insulin resistance in individuals with type 2 diabetes: a double-blind randomised placebo-controlled clinical trial. European Journal of Nutrition. 62(8). 3241–3249. 1 indexed citations
9.
Kamel, Ahmed, et al.. (2023). Effect of Metformin on Oxidative Stress and Left Ventricular Geometry in Nondiabetic Heart Failure Patients: A Randomized Controlled Trial. Metabolic Syndrome and Related Disorders. 22(1). 49–58. 5 indexed citations
10.
11.
Kamel, Ahmed, et al.. (2023). COVID-19 vaccine hesitancy in Egypt: a cross-sectional study. The Journal of Infection in Developing Countries. 17(9). 1188–1198. 2 indexed citations
12.
Kamel, Ahmed, Nirmeen A. Sabry, & Samar Farid. (2022). Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials. BMC Cardiovascular Disorders. 22(1). 405–405. 15 indexed citations
13.
Sabry, Nirmeen A., et al.. (2022). Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial. Thrombosis Journal. 20(1). 44–44. 2 indexed citations
14.
Sabry, Nirmeen A., et al.. (2020). Combined effect of high-dose vitamin A, vitamin E supplementation, and zinc on adult patients with diabetes: A randomized trial. Journal of Advanced Research. 28. 27–33. 34 indexed citations
15.
Sabry, Nirmeen A., et al.. (2020). Short-term Effects of Alfacalcidol on Hospital Length of Stay in Patients Undergoing Valve Replacement Surgery: A Randomized Clinical Trial. Clinical Therapeutics. 43(1). e1–e18. 7 indexed citations
16.
Sabry, Nirmeen A., Samar Farid, & Dalia Dawoud. (2016). Drug-related problems in cardiac children.. PubMed. 68(2). 89–95. 8 indexed citations
17.
Abbassi, Maggie, et al.. (2016). Obesity Does Not Affect Propofol Pharmacokinetics During Hypothermic Cardiopulmonary Bypass. Journal of Cardiothoracic and Vascular Anesthesia. 30(4). 876–883. 8 indexed citations
18.
Abbassi, Maggie, et al.. (2016). Efficacy of Different Perioperative Statin Regimens on Protection Against Post-Coronary Artery Bypass Grafting Major Adverse Cardiac and Cerebral Events. Journal of Cardiothoracic and Vascular Anesthesia. 30(6). 1461–1470. 2 indexed citations
19.
Mohamed, Amal Ahmed, et al.. (2013). Vitamin D levels in Egyptian HCV patients (genotype 4) treated with pegylated interferon.. PubMed. 76(1). 38–44. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eman Abu‐Gharbieh Breakdown of academic impact, for papers by Nusrat Shafiq Breakdown of academic impact, for papers by Torsten Hoppe‐Tichy Breakdown of academic impact, for papers by Katsuhiko Matsuura Breakdown of academic impact, for papers by Nicole Hunfeld Breakdown of academic impact, for papers by Robert Janknegt Breakdown of academic impact, for papers by Henry J. Mann Breakdown of academic impact, for papers by Lynda S. Welage Breakdown of academic impact, for papers by Mark A. Gill Breakdown of academic impact, for papers by Surulivelrajan Mallayasamy
Rankless by CCL
2026